Tools
Tools
Mavhu, Webster 
ORCID: https://orcid.org/0000-0003-1881-4398, Neuman, Melissa, Hatzold, Karin, Buzuzi, Stephen, Maringwa, Galven, Chabata, Sungai T, Mangenah, Collin, Taruberekera, Noah, Madidi, Ngonidzashe, Munjoma, Malvern, Ncube, Getrude, Xaba, Sinokuthemba, Mugurungi, Owen, Johnson, Cheryl C, Corbett, Elizabeth L, Weiss, Helen A, Fielding, Katherine and Cowan, Frances ORCID: https://orcid.org/0000-0003-3087-4422
(2021)
'Innovative demand creation strategies to increase voluntary medical male circumcision uptake: a pragmatic randomised controlled trial in Zimbabwe'. BMJ Global Health, Vol 6, Issue Suppl_4, e006141.
|
Text
bmjgh-2021-006141.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (697kB) | Preview |
Abstract
Introduction: Reaching men aged 20–35 years, the group at greatest risk of HIV, with voluntary medical male circumcision (VMMC) remains a challenge. We assessed the impact of two VMMC demand creation approaches targeting this age group in a randomised controlled trial (RCT). Methods: We conducted a 2×2 factorial RCT comparing arms with and without two interventions: (1) standard demand creation augmented by human-centred design (HCD)-informed approach; (2) standard demand creation plus offer of HIV self-testing (HIVST). Interpersonal communication (IPC) agents were the unit of randomisation. We observed implementation of demand creation over 6 months (1 May to 31 October 2018), with number of men circumcised assessed over 7 months. The primary outcome was the number of men circumcised per IPC agent using the as-treated population of actual number of months each IPC agent worked. We conducted a mixed-methods process evaluation within the RCT. Results: We randomised 140 IPC agents, 35 in each arm. 132/140 (94.3%) attended study training and 105/132 (79.5%) reached at least one client during the trial period and were included in final analysis. There was no evidence that the HCD-informed intervention increased VMMC uptake versus no HCD-informed intervention (incident rate ratio (IRR) 0.87, 95% CI 0.38 to 2.02; p=0.75). Nor did offering men a HIVST kit at time of VMMC mobilisation (IRR 0.65, 95% CI 0.28 to 1.50; p=0.31). Among IPC agents that reported reaching at least one man with demand creation, both the HCD-informed intervention and HIVST were deemed useful. There were some challenges with trial implementation; <50% of IPC agents converted any men to VMMC, which undermined our ability to show an effect of demand creation and may reflect acceptability and feasibility of the interventions. Conclusion: This RCT did not show evidence of an effect of HCD-informed demand intervention or HIVST on VMMC uptake. Findings will inform future design and implementation of demand creation evaluations. Trial registration number: PACTR201804003064160.
| Item Type: | Article |
|---|---|
| Subjects: | WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503.6 Prevention and control WJ Urogenital System > WJ 100 General works |
| Faculty: Department: | Clinical Sciences & International Health > International Public Health Department |
| Digital Object Identifer (DOI): | https://doi.org/10.1136/bmjgh-2021-006141 |
| SWORD Depositor: | JISC Pubrouter |
| Depositing User: | Stacy Murtagh |
| Date Deposited: | 22 Jul 2021 11:01 |
| Last Modified: | 22 Jul 2021 11:01 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/18458 |
Statistics
Actions (login required)
 |
Edit Item |